
About TLR Therapeutics
TLR Therapeutics is a Healthcare company based in Wilmington (United States) founded in 2022. It develops innovative therapeutics for treating myelodysplastic syndrome and gastric cancer. It operates on a B2B model. Its focus areas include Biotechnology, Therapeutics and Cancer Treatment. Its competitors include Intima Bioscience, Ilico Genetics and Kupffer Biotherapeutics; 1 of its 3 listed competitors has raised funding.
Company details
TLR Therapeutics, established in 2022, excels in providing healthcare solutions, advancing biotech innovations, therapeutics, and cancer treatment. Develops innovative therapeutics for treating myelodysplastic syndrome and gastric cancer. Committed to advancing standards, it focuses on innovation, efficiency, and delivering value to clients worldwide.
- Headquarters Wilmington, United States
- SectorsHealthcare
- Website tlrtx.com
Competitors of TLR Therapeutics
TLR Therapeutics has 3 listed competitors in our database, 1 of them funded. They include Intima Bioscience, Ilico Genetics and Kupffer Biotherapeutics.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| intimabioscience.com | 2014 | New York, United States | Therapeutics for gastrointestinal cancer are developed using CRISPR gene-editing. | |||
| ilicogenetics.com | 2020 | Bethlehem, United States | $457,735 | Developer of diagostic test for detection of gastric cancer | ||
| kupfferbio.com | 2019 | Burlingame, United States | Develops innovative technologies for anticancer therapies targeting gastrointestinal cancers. |
Detailed competitors of TLR Therapeutics
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Immunology & Cancer Therapeutics
3 companies that operate in the same segment as TLR Therapeutics (Immunology & Cancer Therapeutics) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Targeted and immune-oncology drugs for cancer treatment are developed. | 2010 | Cambridge, Massachusetts, United States | USD 172 M | |||
Immuno-modulatory therapies for dementia and neurodegenerative disorders are developed. | 2013 | San Francisco, California, United States | USD 214.78 M | USD 21.05 M | 211 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about TLR Therapeutics
TLR Therapeutics was founded in 2022.
TLR Therapeutics is headquartered in Wilmington, United States. It is registered at Wilmington, Delaware, United States.
TLR Therapeutics, established in 2022, excels in providing healthcare solutions, advancing biotech innovations, therapeutics, and cancer treatment. Develops innovative therapeutics for treating myelodysplastic syndrome and gastric cancer. Committed to advancing standards, it focuses on innovation, efficiency, and delivering value to clients worldwide.
TLR Therapeutics's top competitors include Ilico Genetics, Intima Bioscience and Kupffer Biotherapeutics.